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ABSTRACT   
Synthesizing the appearance of malignant masses and inserting these into digital mammograms can be used as part of a 
wider framework for investigating the radiological detection task in X-ray mammography. However, the randomness 
associated with cell division within cancerous masses and the associated complex morphology challenges the realism of 
the modeling process. In this paper, Diffusion Limited Aggregation (DLA), a type of fractal growth process is proposed 
and utilized for modeling breast lesions.  Masses of different sizes, shapes and densities were grown by controlling DLA 
growth parameters either prior to growth, or dynamically updating these during growth. A validation study was 
conducted by presenting 30 real and 30 simulated masses in a random order to a team of radiologists. The results from 
the validation study suggest that the observers found it difficult to differentiate between the real and simulated lesions. 
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1. INTRODUCTION  
Breast cancer can be described as the abnormal division of cells in breast tissues and accounts for approximately 17% of 
all  cancers wordwide1. Early diagnosis and treatment of breast cancer is known to be a key factor in reducing mortality 
rates and has motivated the introduction of national screening programmes in many western countries. Although X-ray 
film screen imaging has historically been the screening method of choice, there has been a shift over recent years 
towards using various digital imaging alternatives as these offer a number of advantages over film screen2. However the 
relative merits of these competing technologies, with respect to the detection task is unclear. One approach to address 
this issue is to develop an image simulation chain in order to conduct virtual trials, presenting pathology to the 
radiologist that is representative in appearance to that produced on different imaging systems or with different imaging 
protocols.  
Prior work in this area has used the process of random walks3,4 in 2D, shape descriptors5 and quantitative measurements6 
from real masses to simulate the appearance of lesions in mammograms. However, most of these prior methods were 
designed for realistic appearance of simulated lesions in digitized films. In contrast to this approach, we introduce DLA 
(Diffusion Limited Aggregation), which is a fractal-like growth process to generate the appearance of lesions when 
inserted into digital mammograms. The fundamental advantage of using DLA is that the there is far greater control 
available in terms of the simulated lesion morphology7.   
2. MATERIALS AND METHODS  
2.1 Mass generation using DLA 
Diffusion Limited Aggregation is a type of fractal growth process in which particles undergoing random walk (Brownian 
motion) cluster together and form aggregates8. The process may be explained, for simplicity in 2D, by starting with a  
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nominated growth center as the initial mass center. This is surrounded by concentric launch circles in 2D (spheres in 
3D). Random walk processes are then launched from these circles, in some prescribed manner (see Fig. 1a). If the path of 
the random walk touches the growth center, then this adjacent site is labeled as part of the growth center or cluster. If a 
random walk fails to touch the growing mass center, then it is simply discarded and does not contribute further to the 
growth process. This process is repeated by launching many random walks from the launch circles in some prescribed 
manner, and thus the growth center steadily accumulates in size and grows until some terminal condition is reached. 
Figure 1 illustrates the growth of a DLA cluster alongside some examples of simulated masses grown using the DLA 
method. The structure of the DLA mass can be controlled by varying the parameters listed in Table 1 (also illustrated in 
Fig. 1) which provides flexible control of the microscopic appearance of lesion before it is digitally re-sampled and 
inserted into a mammogram. Each of the growth parameters has a different level of impact on the structure of the DLA 
cluster. A cluster formed by the DLA process follows well known fractal properties such as self similarity, irregular 
geometry and fine structure at arbitrarily small scales. DLA fractals can also be measured by the ‘Fractal Dimension’ 
metric, a statistical quantity that gives an indication of occupancy of a fractal at a given scale.  
                   
       Figure 1. (a)-(f)  The DLA growth process. (g)-(j) A set of four examples of masses grown using DLA but with 
very different parameter prescriptions. 
 
Table 1. DLA parameters and inference  
Parameter Details Impact on the mass 
ρ 
∆C 
∆S 
N 
Ps 
Density of points on launching circle/sphere 
Spacing between launch circles/spheres 
Step size of random walk 
Total number of launching points  
Sticking probability 
Texture  
Size  
Density  
Size 
Density 
 
For the current experimentation, numerous DLA masses were grown by extending the aforementioned 2D growth 
process to a three-dimensional lattice (voxel size: 35μm). Parameter selection was guided using the results of a pilot 
study that provided expert feedback on mass simulation appearance. The most appropriate range of parameters involved 
simulated DLA masses with 105≤N≤107, 16≤ΔS≤64 and .001≤PS≤1 for generating lesions with realistic appearance. 
While growing certain masses, the step size was dynamically varied in order to generate masses with dense centers. This 
was accomplished by initiating the growth process with a bigger step size and switching to a smaller step size after the 
mass had reached a certain size. In some cases, sticking probability was set to a lower value to achieve a dense center. 
Sticking probability is the probability of a particle undergoing random walk to stick to an occupied site when it comes in 
contact with it. Due to the fractal nature of DLA and the random walk process, repeated simulation of DLA masses with 
identical parameters yielded masses with broadly similar shape but different individual appearance. The masses were 
quantified by size (S) and fractal dimension (D). The size was estimated by constructing a bounding sphere that 
encompasses all the points of a DLA mass and using the resulting diameter of the fitted sphere. The fractal dimension 
(g) (h) 
(j) (i)
∆C 
∆S 
ρ 
Ps
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was estimated from the radius of gyration plot8, which shows how the average distance between the points of a DLA 
mass and the centre varies with increasing N (launch points). The relation follows a power law with a positive exponent 
(G(r) ~r-β). If β is the slope of the curve on a log scale, then the fractal dimension is given by (1/β). Masses were 
simulated with an apparent size range between 6mm and 15mm and the fractal dimension range between 2.7 and 2.9. 
The lesions were inserted into raw clinical mammograms at random locations using the approach explained in section 
2.2. 
 
2.2 Insertion 
Each mass was grown within a pre-defined 3D array that was sufficient large to ensure that the resulting mass would not 
experience any boundary effects near the edge of the array. In order to insert the mass with the appropriate contrast, 
Volpara software9 was utilized to estimate the local breast composition from the raw digital mammogram prior to mass 
insertion. Volpara generates a density map of the raw mammogram with values representing the volume of the dense 
tissue above each pixel point. Using metadata available from the DICOM header (breast thickness, source-to-detector 
(SID) and spectrum information) the relative increase in attenuation due to the mass at the insertion site was estimated. 
The resulting 2D array of transmission factors was then filtered employing the method described by Yip et al10, using the 
MTF (Modulation Transfer Function) and pixel sampling representative of the image acquisition process of an Hologic 
mammography system (Bedford, Massachusetts, USA). In order to account for scatter at the insertion site, a look-up 
table of SPR (Scatter-to-Primary Ratio) values was generated from Monte Carlo simulation data for a range of breast 
thicknesses and glandularities. Scatter was accounted for by first estimating the scatter present at the insertion site, using 
the aforementioned metadata and then initially subtracted from this region in order to estimate an appropriate 
transmission factor of the primary beam. The transmission factor of the primary was then modified to account for the 
relative increase in attenuation due to insertion of the mass. Only then was the scatter added back into the image to 
ensure that both processes (transmission and scatter components) were appropriately accounted for, and thus realistic 
mass contrast was obtained. A detailed description of the insertion process, is given in Rashidnasab et al11. The entire 
mammogram was then passed through the Hologic LORAD FFDM Selenia V5.0 image processing package to produce a 
digital mammogram suitable for viewing. 
 
 
Figure 2. Protocol for mass insertion into real mammograms 
2.3 Validation Study 
The raw mammograms with inserted DLA masses were processed using manufacturer image processing software and 
compared with mammograms containing real masses. The processed mammograms with inserted DLA masses were 
presented to 7 expert radiologists for independent observation wherein the lesions were a-priori identified by specifying 
their approximate location in the mammogram. A total of 60 mammograms (30 pathology proven malignant cases and 30 
normal mammograms with simulated masses) were presented in random order to the readers. The dataset was 
individually randomized for each reader to make sure every mammogram was equally likely to appear at the start, 
middle or end of the dataset. This was to avoid bias due to observer fatigue. The average clinical screening experience of 
the observers who participated in the validation study was around 6 years. Observer assessment required rating the 
realism of the mass on a 5 point scale categorized as: 1.definitely simulated, 2.probably simulated, 3.indeterminate, 
4.probably real and 5.definitely real, and the level of suspicion as: 1.normal, 2.benign, 3.indeterminate, 4.suspicious and 
5.malignant. A screenshot of the GUI utilized for the study is shown in Figure 3, which was developed in-house as a Java 
plug-in to ImageJ12.  
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Figure 3. Graphical user interface used for the validation study. 
 
3. RESULTS AND DISCUSSION 
 
 
Figure 4. Example mammograms with inserted DLA masses. Thumbnails show insertion regions in detail. 
 
A selection of inserted DLA masses is shown in Figure 4.  Figure 5 shows the histogram of observers’ ratings on the 
realism of the masses. It is apparent from the nature of the histogram that observers had difficulty in differentiating real 
masses from those simulated using DLA. Subsequently, ROC analysis was performed to confirm this observation. Table 
 
 
 
 
2 and Figure 6 show the results of ROC analysis in which the False Positive Fraction (FPF) was plotted against the True 
Positive Fraction (TPF) for each observer, and AUC (Area Under Curve) estimated using the trapezoidal method. The 
Confidence Interval (CI) was calculated using the method presented in Hanley et al13. This suggests that for all observers 
used here, no statistically significant difference was found between ratings of real and DLA simulated masses. The 
overall mean of the AUC was 0.50±.06, which implies that the likelihood of an observer to correctly identify a simulated 
lesion is essentially random. Figure 7 shows the histogram of observers’ ratings of the masses in terms of suspicion. It 
was not surprising to see most of simulated lesions being rated as a ‘recall’ as simulated lesions were designed to appear 
malignant. On the contrary, it was interesting to see that some of the real masses which were originally recalled where 
not rated as a ‘recall’ by the observers; this demonstrates a degree of inter-observer variations which might be expected. 
 
0
10
20
30
40
50
60
70
80
90
100
1 2 3 4 5
Def Sim            Prob Sim          Indeterminate           Prob Real           Def Real 
Nu
m
be
r o
f C
as
es
Real masses
Simulated DLA masses
  
Figure 5. Global histogram of ratings on the realism of the mass for all the observers. 
 
 
 
Figure 6. ROC curves of the ratings of the masses per observer. 
 
 
 
 
 
 
Table 2. ROC analysis results 
 
Observer 
 
Area Under Curve 
 
95% Confidence 
Interval 
Observer 1 
Observer 2 
Observer 3 
Observer 4 
Observer 5 
Observer 6 
Observer 7 
Average 
0.49 
0.57 
0.43 
0.40 
0.60 
0.53 
0.49 
0.50 
( 0.34 , 0.63) 
(0.42,  0.71) 
(0.29,  0.58) 
(0.26,  0.54) 
(0.46,  0.75) 
(0.38,  0.67) 
(0.34,  0.64) 
(0.44,  0.56) 
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Figure 7. Global histogram of ratings on the level of suspicion for all the observers. 
4. CONCLUSION 
In this paper, we have introduced a new method for generating synthetic masses, Diffusion Limited Aggregation. From 
the pilot study it was observed that the realism was critically dependant on a combination of parameter selection and 
nature of the insertion site. Thus, in the current study we used local estimates of the glandularity at the insertion site to 
control the apparent contrast of the mass. The results of an ROC study suggest that masses generated using DLA may be 
indistinguishable in appearance from genuine pathologically-confirmed masses. 
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